Cumulative exposure to stimulants and immune function outcomes among HIV-positive and HIV-negative men in the Multicenter AIDS Cohort Study

S. Shoptaw, R. Stall, J. Bordon, U. Kao, Christopher Cox, Xiuhong Li, D. G. Ostrow, M. W. Plankey

Research output: Contribution to journalArticle

Abstract

We examined associations between stimulant use (methamphetamine and cocaine) and other substances (nicotine, marijuana, alcohol and inhaled nitrites) with immune function biomarkers among HIV-seropositive (HIV {thorn}) men taking highly active antiretroviral therapy (ART) and HIV-seronegative (HIV2) men in the Multicenter AIDS Cohort Study. Among HIV {thorn} men, cumulative adherence to ART (4.07, 95% confidence interval [CI]: 3.52, 4.71, per 10 years of adherent ART use), and recent cohort enrolment (1.38; 95% CI: 1.24, 1.55) were multiplicatively associated with increase in CD4+/CD8+ ratios. Cumulative use of methamphetamine (0.93; 95% CI: 0.88, 0.98, per 10 use-years), cocaine (0.93; 95% CI: 0.89, 0.96, per 10 use-years) and cumulative medical visits (0.99; 95% CI: 0.98, 0.99, per 10 visit-years), each showed small negative associations with CD4+/CD8+ ratios. Among HIV2 men, cumulative medical visits (0.996; 95% CI: 0.993, 0.999), cumulative number of male sexual partners (0.999; 95% CI: 0.998, 0.9998, per 10 partner-years) and cigarette pack-years (1.10; 95% CI: 1.02, 1.18, per 10 pack-years) were associated with CD4+/CD8+ ratios over the same period. ART adherence is associated with a positive immune function independent of stimulant use, underscoring the influence of ART on immune health for HIV{thorn} men who engage in stimulant use.

Original languageEnglish (US)
Pages (from-to)576-580
Number of pages5
JournalInternational Journal of STD and AIDS
Volume23
Issue number8
DOIs
StatePublished - Aug 2012

Fingerprint

Acquired Immunodeficiency Syndrome
Cohort Studies
HIV
Confidence Intervals
CD4-CD8 Ratio
Methamphetamine
Cocaine
Sexual Partners
Highly Active Antiretroviral Therapy
Therapeutics
Cannabis
Nitrites
Nicotine
Tobacco Products
Biomarkers
Alcohols
Health

Keywords

  • Adherence
  • Antiretroviral therapy
  • CD4+/CD8+ ratio
  • Cocaine
  • HIV
  • Men
  • Methamphetamine
  • Multicenter AIDS Cohort Study

ASJC Scopus subject areas

  • Dermatology
  • Public Health, Environmental and Occupational Health
  • Pharmacology (medical)
  • Infectious Diseases

Cite this

Cumulative exposure to stimulants and immune function outcomes among HIV-positive and HIV-negative men in the Multicenter AIDS Cohort Study. / Shoptaw, S.; Stall, R.; Bordon, J.; Kao, U.; Cox, Christopher; Li, Xiuhong; Ostrow, D. G.; Plankey, M. W.

In: International Journal of STD and AIDS, Vol. 23, No. 8, 08.2012, p. 576-580.

Research output: Contribution to journalArticle

@article{a6e2fed98413488990ed18fde1814357,
title = "Cumulative exposure to stimulants and immune function outcomes among HIV-positive and HIV-negative men in the Multicenter AIDS Cohort Study",
abstract = "We examined associations between stimulant use (methamphetamine and cocaine) and other substances (nicotine, marijuana, alcohol and inhaled nitrites) with immune function biomarkers among HIV-seropositive (HIV {thorn}) men taking highly active antiretroviral therapy (ART) and HIV-seronegative (HIV2) men in the Multicenter AIDS Cohort Study. Among HIV {thorn} men, cumulative adherence to ART (4.07, 95{\%} confidence interval [CI]: 3.52, 4.71, per 10 years of adherent ART use), and recent cohort enrolment (1.38; 95{\%} CI: 1.24, 1.55) were multiplicatively associated with increase in CD4+/CD8+ ratios. Cumulative use of methamphetamine (0.93; 95{\%} CI: 0.88, 0.98, per 10 use-years), cocaine (0.93; 95{\%} CI: 0.89, 0.96, per 10 use-years) and cumulative medical visits (0.99; 95{\%} CI: 0.98, 0.99, per 10 visit-years), each showed small negative associations with CD4+/CD8+ ratios. Among HIV2 men, cumulative medical visits (0.996; 95{\%} CI: 0.993, 0.999), cumulative number of male sexual partners (0.999; 95{\%} CI: 0.998, 0.9998, per 10 partner-years) and cigarette pack-years (1.10; 95{\%} CI: 1.02, 1.18, per 10 pack-years) were associated with CD4+/CD8+ ratios over the same period. ART adherence is associated with a positive immune function independent of stimulant use, underscoring the influence of ART on immune health for HIV{thorn} men who engage in stimulant use.",
keywords = "Adherence, Antiretroviral therapy, CD4+/CD8+ ratio, Cocaine, HIV, Men, Methamphetamine, Multicenter AIDS Cohort Study",
author = "S. Shoptaw and R. Stall and J. Bordon and U. Kao and Christopher Cox and Xiuhong Li and Ostrow, {D. G.} and Plankey, {M. W.}",
year = "2012",
month = "8",
doi = "10.1258/ijsa.2012.011322",
language = "English (US)",
volume = "23",
pages = "576--580",
journal = "International Journal of STD and AIDS",
issn = "0956-4624",
publisher = "SAGE Publications Ltd",
number = "8",

}

TY - JOUR

T1 - Cumulative exposure to stimulants and immune function outcomes among HIV-positive and HIV-negative men in the Multicenter AIDS Cohort Study

AU - Shoptaw, S.

AU - Stall, R.

AU - Bordon, J.

AU - Kao, U.

AU - Cox, Christopher

AU - Li, Xiuhong

AU - Ostrow, D. G.

AU - Plankey, M. W.

PY - 2012/8

Y1 - 2012/8

N2 - We examined associations between stimulant use (methamphetamine and cocaine) and other substances (nicotine, marijuana, alcohol and inhaled nitrites) with immune function biomarkers among HIV-seropositive (HIV {thorn}) men taking highly active antiretroviral therapy (ART) and HIV-seronegative (HIV2) men in the Multicenter AIDS Cohort Study. Among HIV {thorn} men, cumulative adherence to ART (4.07, 95% confidence interval [CI]: 3.52, 4.71, per 10 years of adherent ART use), and recent cohort enrolment (1.38; 95% CI: 1.24, 1.55) were multiplicatively associated with increase in CD4+/CD8+ ratios. Cumulative use of methamphetamine (0.93; 95% CI: 0.88, 0.98, per 10 use-years), cocaine (0.93; 95% CI: 0.89, 0.96, per 10 use-years) and cumulative medical visits (0.99; 95% CI: 0.98, 0.99, per 10 visit-years), each showed small negative associations with CD4+/CD8+ ratios. Among HIV2 men, cumulative medical visits (0.996; 95% CI: 0.993, 0.999), cumulative number of male sexual partners (0.999; 95% CI: 0.998, 0.9998, per 10 partner-years) and cigarette pack-years (1.10; 95% CI: 1.02, 1.18, per 10 pack-years) were associated with CD4+/CD8+ ratios over the same period. ART adherence is associated with a positive immune function independent of stimulant use, underscoring the influence of ART on immune health for HIV{thorn} men who engage in stimulant use.

AB - We examined associations between stimulant use (methamphetamine and cocaine) and other substances (nicotine, marijuana, alcohol and inhaled nitrites) with immune function biomarkers among HIV-seropositive (HIV {thorn}) men taking highly active antiretroviral therapy (ART) and HIV-seronegative (HIV2) men in the Multicenter AIDS Cohort Study. Among HIV {thorn} men, cumulative adherence to ART (4.07, 95% confidence interval [CI]: 3.52, 4.71, per 10 years of adherent ART use), and recent cohort enrolment (1.38; 95% CI: 1.24, 1.55) were multiplicatively associated with increase in CD4+/CD8+ ratios. Cumulative use of methamphetamine (0.93; 95% CI: 0.88, 0.98, per 10 use-years), cocaine (0.93; 95% CI: 0.89, 0.96, per 10 use-years) and cumulative medical visits (0.99; 95% CI: 0.98, 0.99, per 10 visit-years), each showed small negative associations with CD4+/CD8+ ratios. Among HIV2 men, cumulative medical visits (0.996; 95% CI: 0.993, 0.999), cumulative number of male sexual partners (0.999; 95% CI: 0.998, 0.9998, per 10 partner-years) and cigarette pack-years (1.10; 95% CI: 1.02, 1.18, per 10 pack-years) were associated with CD4+/CD8+ ratios over the same period. ART adherence is associated with a positive immune function independent of stimulant use, underscoring the influence of ART on immune health for HIV{thorn} men who engage in stimulant use.

KW - Adherence

KW - Antiretroviral therapy

KW - CD4+/CD8+ ratio

KW - Cocaine

KW - HIV

KW - Men

KW - Methamphetamine

KW - Multicenter AIDS Cohort Study

UR - http://www.scopus.com/inward/record.url?scp=84865814357&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865814357&partnerID=8YFLogxK

U2 - 10.1258/ijsa.2012.011322

DO - 10.1258/ijsa.2012.011322

M3 - Article

C2 - 22930295

AN - SCOPUS:84865814357

VL - 23

SP - 576

EP - 580

JO - International Journal of STD and AIDS

JF - International Journal of STD and AIDS

SN - 0956-4624

IS - 8

ER -